Product Information
CHLORPROMAZINE 25 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.3244 per EA under NDC 62135042190. Its NADAC has been published 190 times since Feb 15, 2023.
FDA first approved this application on Nov 29, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Chartwell RX LLCNDC
62135042190
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212630FDA Approved
11/29/2021
TE Code
AB
On Market Since
2/5/2022
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 25 MG TABLET has been published 190 times since Feb 15, 2023, and over the history we have for it it has declined 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3244 per EA |
|---|---|
| All-time high | $0.7478 (Dec 13, 2023) |
| All-time low | $0.2846 (Jul 22, 2026) |
| 52-week high | $0.3883 |
| 52-week low | $0.2846 |
| Median price | $0.3721 |
| Average price | $0.4064 |
| Largest weekly change | +36.8% (Nov 22, 2023) |
| Weeks tracked | 190 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the chlorpromazine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
chlorpromazine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 25 MG TABLET, manufactured by Chartwell RX LLC, is $0.3244 per EA (NDC 62135042190), effective Sep 30, 2026.
How has the price of CHLORPROMAZINE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 25 MG TABLET has declined 12.8%. It has been tracked across 190 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 25 MG TABLET?
Since Feb 15, 2023, the NADAC for CHLORPROMAZINE 25 MG TABLET has ranged from a low of $0.2846 (Jul 22, 2026) to a high of $0.7478 (Dec 13, 2023), with a median of $0.3721 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 25 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CHLORPROMAZINE 25 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORPROMAZINE 25 MG TABLET?
CHLORPROMAZINE 25 MG TABLET (NDC 62135042190) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.